text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 174-78-7 | Product Number: O0466

2-Oxa-6-azaspiro[3.3]heptane


Purity: >98.0%(GC)
Synonyms:
Product Documents:
1G
€245.00
2   ≥100 

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number O0466
Purity / Analysis Method >98.0%(GC)
Molecular Formula / Molecular Weight C__5H__9NO = 99.13 
Physical State (20 deg.C) Liquid
Storage Temperature Frozen (<0°C)
Store Under Inert Gas Store under inert gas
Condition to Avoid Air Sensitive,Heat Sensitive
CAS RN 174-78-7
Reaxys Registry Number 18835134
PubChem Substance ID 354335112
MDL Number

MFCD12407093

Specifications
Appearance Colorless to Almost colorless clear liquid
Purity(GC) min. 98.0 %
Purity(Neutralization titration) min. 97.0 %
NMR confirm to structure
Properties (reference)
Flash point 51 °C
Refractive Index 1.48
GHS
Pictogram Pictogram Pictogram
Signal Word Warning
Hazard Statements H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
H226 : Flammable liquid and vapour.
Precautionary Statements P210 : Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
P370 + P378 : In case of fire: Use dry sand, dry chemical or alcohol-resistant foam to extinguish.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P303 + P361 + P353 : IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water.
Related Laws:
Transport Information:
UN Number UN1993
Class 3
Packing Group III
HS Number 2934999090
Application
A Synthetic Intermediate of Bioactive Substances, such as EGFR Kinase Inhibitors and LRRK2 Inhibitors

This product is used for the synthesis of bioactive substances, such as epidermal growth factor receptor (EGFR) kinase inhibitors for cancer, and leucine rich repeat kinase 2 (LRRK2) inhibitors for Parkinson's disease.

References


PubMed Literature


Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.